MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,312K
EPS
$0.14
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2024-12-31
Revenues
0
0
0
33*
Cost of revenue
0
0
0
37*
Gross profit
0
0
0
-4*
Research and development expense
3,201
2,251
1,643
655*
General and administrative expense
1,362
1,288
1,613
1,128*
Net expenses related to opko collaboration agreement
4,563
3,539
3,256
1,782*
Operating loss
-4,563
-3,539
-3,256
-1,786*
Financial expenses (income), net
-2,749
34
56
-2*
Income (loss) from continuing operations before income taxes, noncontrolling interest
-
-
-
-1,788*
Income tax expense (benefit)
-
-
-
4*
Segment net loss
-7,312
-3,505
-3,200
-1,792
Basic EPS
0.14
0.07
0.07
-0.047
Diluted EPS
0.14
0.07
0.07
-0.047
Basic Average Shares
50,451,232
47,756,409
47,089,814
38,215,765
Diluted Average Shares
50,451,232
47,756,409
47,089,814
38,215,765
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Segment net loss
-$7,312K
Operating loss
-$4,563K
Financial expenses
(income), net
-$2,749K
Net expenses
related to opko...
$4,563K
Research and development
expense
$3,201K
General and
administrative expense
$1,362K
Buy us a coffee
Entera Bio Ltd. (ENTX)
Entera Bio Ltd. (ENTX)